Price
No data yet.
Social Signal Score
Revenue
$1.08B+823.36%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Paul John Chaplin
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1,795
- Beta
- 0.94
- Country
- DK
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 9.17
Financials
Revenue
$1.08B+823.4%Net Income
$17.23MEBITDA
$169.01MFree Cash Flow
$-796.95MEPS (diluted)
$0.07Shares Outstanding (diluted)
231.43M+113.0%Operating Expenses
$489.21MCash & Debt
$2.29BReturn of Capital
$227.25MDividend per Share
$0.43Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.93B | $1.32B | $5.66 |
| 2024 | $5.72B | $987.98M | $4.20 |
| 2023 | $7.06B | $1.48B | $6.41 |
| 2022 | $3.15B | $-347.38M | $-1.64 |
| 2021 | $1.90B | $-464.77M | $-2.46 |
| 2020 | $1.85B | $277.52M | $1.71 |
| 2019 | $662.49M | $-346.78M | $-2.83 |
| 2018 | $500.62M | $-361.93M | $-2.96 |
| 2017 | $1.37B | $181.34M | $1.50 |
| 2016 | $1.01B | $30.60M | $0.26 |
| 2015 | $1.02B | $59.43M | $0.55 |
| 2014 | $1.22B | $25.94M | $0.26 |
| 2013 | $1.21B | $-46.73M | $-0.47 |
| 2012 | $1.02B | $-240.00M | $-2.43 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $8.30
- Implied price
- $91.32
- Return from $10.88
- 53.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $45.40 — today's price is already 76.0% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 7 | 9 | 11 | 13 | 15 |
|---|---|---|---|---|---|
| -2.0% | 26.9% | 33.4% | 38.9% | 43.6% | 47.8% |
| 3.0% | 33.3% | 40.2% | 46.0% | 50.9% | 55.3% |
| 8.0% | 39.8% | 47.0% | 53.0% | 58.2% | 62.8% |
| 13.0% | 46.3% | 53.8% | 60.1% | 65.6% | 70.4% |
| 18.0% | 52.8% | 60.6% | 67.2% | 72.9% | 77.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·1d ago·Positive
Bavarian Nordic A/S (BVNRY) Q2 2026 Earnings Call Transcript Bavarian Nordic A/S (BVNRY) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Typical surprise -32.9% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Mar 5$0.47 vs $0.40beat
- Fri, Nov 15$0.04 vs $0.24miss
Estimates and results for BVNRY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.